Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis. (Q43057636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Eishin Oki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Kazushi Tsuruga

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Tomomi Aizawa-Yashiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Yuya Ito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Norihiro Sato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Yukihiko Kawasaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Junzo Suzuki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

1 reference

19 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1049-1054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20490589%20AND%20SRC:MED&resulttype=core&format=json

Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients

3 February 2020

cites work

1 reference

12 December 2020

The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats

1 reference

12 December 2020

Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.

1 reference

12 December 2020

Long-term mizoribine intermittent pulse therapy, but not azathioprine therapy, attenuated histologic progression in a patient with severe lupus nephritis

1 reference

12 December 2020

Mizoribine: mode of action and effects in clinical use.

1 reference

12 December 2020

Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy

1 reference

12 December 2020

Mammalian HSP60 is a major target for an immunosuppressant mizoribine

1 reference

12 December 2020

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

12 December 2020

Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group

1 reference

12 December 2020

Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy

1 reference

12 December 2020

Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy

1 reference

12 December 2020

Accumulation of macrophages expressing myeloid-related protein 8 associated with the progression of sclerotic changes in children with IgA nephropathy.

1 reference

12 December 2020

Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein

1 reference

12 December 2020